General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China; Nanjing Occupational Disease Prevention Hospital, Nanjing 210042, Jiangsu, China.
General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, Jiangsu, China.
Pathol Res Pract. 2021 Jan;217:153268. doi: 10.1016/j.prp.2020.153268. Epub 2020 Nov 4.
A growing number of studies have shown that long non-coding RNAs (lncRNAs) play an important role in the occurrence and development of tumors. In this study, we explored the function and molecular mechanism of lncRNA SPINT1-AS1 in breast cancer progression.
A total of 30 patients and 25 healthy controls were enrolled to detect the expression of SPINT1-AS1 in the serum by RT-qPCR. CCK-8 assay, clone formation assay, EdU assay, Transwell assay, Flow cytometry for apoptosis assay and wound healing assays were used to explore the effects of SPINT1-AS1 on the proliferation and migration of breast cancer cells. Bioinformatics analysis were used to enrich the downstream target genes and related pathways of miRNAs interacting with SPINT1-AS1, construct a competitive endogenous RNA (ceRNA) network diagram.
SPINT1-AS1 is up-regulated in the serum of breast cancer patients and breast cancer cell lines. The proliferation and migration ability of breast cancer cells were decreased significantly after SPINT1-AS1 knockdown, and it may inhibit its expression by sponging miR-let-7a/b/i-5p, thereby promoting breast cancer progression.
SPINT1-AS1 can promote the proliferation and migration of breast cancer cells by regulating miR-let-7a/b/i-5p, suggesting that it may be an important regulator of breast cancer progression.
越来越多的研究表明,长链非编码 RNA(lncRNA)在肿瘤的发生和发展中起着重要作用。在这项研究中,我们探讨了 lncRNA SPINT1-AS1 在乳腺癌进展中的功能和分子机制。
共纳入 30 例患者和 25 例健康对照者,通过 RT-qPCR 检测血清中 SPINT1-AS1 的表达。CCK-8 检测、克隆形成检测、EdU 检测、Transwell 检测、流式细胞术检测细胞凋亡、划痕愈合实验用于探讨 SPINT1-AS1 对乳腺癌细胞增殖和迁移的影响。生物信息学分析用于富集与 SPINT1-AS1 相互作用的 miRNAs 的下游靶基因及相关通路,构建竞争性内源 RNA(ceRNA)网络图。
SPINT1-AS1 在乳腺癌患者和乳腺癌细胞系的血清中上调。SPINT1-AS1 敲低后,乳腺癌细胞的增殖和迁移能力明显下降,其可能通过海绵吸附 miR-let-7a/b/i-5p 来抑制其表达,从而促进乳腺癌的进展。
SPINT1-AS1 可通过调节 miR-let-7a/b/i-5p 促进乳腺癌细胞的增殖和迁移,提示其可能是乳腺癌进展的重要调控因子。